跳至主要内容
临床试验/NCT05608629
NCT05608629已完成不适用

Vagus Nerve Stimulation as Treatment for Long Covid

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2022年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
1
主要终点
Number of Participants With Treatment Success

研究概览

简要总结

Many patients do not recover following Covid infection. The resulting illness is called Long Covid. Because there is no agreed upon treatment for this ailment, the research team has decided to do an open label pilot study using non-invasive, transcutaneous stimulation of the auricular branch of the vagus nerve. Inclusion criteria required the patient to fulfill criteria for having chronic fatigue syndrome. To date, fourteen patients provided evaluable data. Eight of these fulfilled the study's requirements for treatment success.

详细描述

Patients who have had COVID and who fulfill criteria for chronic fatigue syndrome will sign IC and be mailed a parasym device with instructions its use after completing entry baseline questionnaires. Subjects will be called two, four and six weeks after beginning participation [application of electrode to left tragus with stimulus intensity at that which is just below pain threshold for 35 min a day] to ask about adverse events. At the end of 6 weeks, patients will complete these questionnaires again plus one assessing their assessment of treatment efficacy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients had to have had COVID
  • Patients have to fulfill the 1994 case definition for chronic fatigue syndrome.

排除标准

  • BMI > 30

结局指标

主要结局

Number of Participants With Treatment Success

时间窗: Baseline to post-treatment at 6-weeks

Treatment success is defined as patient had to improve on 2 of the following: a 14% improvement in SF-36 -- physical function (0-100 scale, higher score = less disability; report of marked or moderate improvement (2-3 on a scale going from +3 to -3\] based on the treatment \[patient global indication of change (0-7, higher score = more improvement); going from fatigue case to no fatigue on Chalder fatigue scale (0-3, higher score = more fatigue; improvement on VAS of at least 2 points \[VAS going from none \[0\] to 5 \[very severe\] with at least a 3 \[substantial\] on one of the following Sx --\> fatigue, brain fog, widespread pain

次要结局

  • Number of Participants With Change in the Profile of Mood States (POMS)(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamin Natelson

Professor of Neurology

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验